The 2024 Gold Rush: Unleashing Market Potential

Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.

Get your free information kit NOW, before it's too late.

DCPH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.43%

Insider Buying (Last 12 Months): $291,260.00

Insider Selling (Last 12 Months): $470,122.61

Deciphera Pharmaceuticals Insider Trading History Chart

Deciphera Pharmaceuticals Share Price & Price History

^$25.38

▲ +0.01 (0.04%)

As of 05/9/2024 04:40 PM ET

Days: 30 | 90 | 365

Gold Set to EXPLODE!

From Gold Safe Exchange | Ad

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Deciphera Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Jama Pitman	SVP	Sell	1,624	$14.47	$23,499.28	50,573
1/16/2024	Matthew L. Sherman	EVP	Sell	2,435	$14.47	$35,234.45	94,079
10/30/2023	Jama Pitman	Insider	Sell	1,407	$12.02	$16,912.14	48,283
10/30/2023	Matthew L. Sherman	EVP	Sell	2,360	$12.02	$28,367.20	90,628
10/30/2023	Steven L Hoerter	CEO	Sell	21,573	$12.02	$259,307.46	40,927
10/30/2023	Thomas Patrick Kelly	CFO	Sell	2,316	$12.02	$27,838.32	63,068
10/2/2023	Matthew L. Sherman	EVP	Sell	2,942	$12.68	$37,304.56	84,744
6/16/2023	Jama Pitman	Insider	Sell	1,238	$14.40	$17,827.20	43,812
6/16/2023	Matthew L. Sherman	EVP	Sell	1,655	$14.40	$23,832.00	87,686
6/8/2023	Franklin Stuart Friedman	Director	Buy	10,000	$13.88	$138,800.00	10,000
5/10/2023	Dennis Leo Walsh	Director	Buy	11,000	$13.86	$152,460.00	11,000
3/21/2023	Steven L. Hoerter	CEO	Sell	7,500	$15.57	$116,775.00
2/16/2023	Daniel C Martin	Insider	Sell	1,159	$15.10	$17,500.90	58,381
2/16/2023	Matthew L. Sherman	EVP	Sell	971	$15.10	$14,662.10	88,145
2/16/2023	Thomas Patrick Kelly	CFO	Sell	1,370	$15.10	$20,687.00	58,795
1/24/2023	Brightstar Associates Llc	Major Shareholder	Buy	1,666,666	$18.00	$29,999,988.00	19,718,014
1/17/2023	Daniel Lee Flynn	Insider	Sell	2,403	$21.24	$51,039.72	43,695
10/3/2022	Matthew L. Sherman	EVP	Sell	2,587	$18.73	$48,454.51	74,297
6/16/2022	Jama Pitman	Insider	Sell	1,298	$10.75	$13,953.50	36,661
6/16/2022	Matthew L. Sherman	EVP	Sell	1,768	$10.75	$19,006.00	76,884
4/29/2022	Brightstar Associates Llc	Major Shareholder	Buy	1,478,978	$10.00	$14,789,780.00	18,051,348
2/16/2022	Daniel Lee Flynn	Insider	Sell	1,366	$9.05	$12,362.30
2/16/2022	Matthew L. Sherman	EVP	Sell	984	$9.05	$8,905.20
2/16/2022	Thomas Patrick Kelly	CFO	Sell	1,368	$9.05	$12,380.40
10/4/2021	Matthew L. Sherman	EVP	Sell	2,659	$33.17	$88,199.03

1970’s computer coder Issues Shocking AI Warning

From InvestorPlace | Ad

Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.

Click here to watch his new video ASAP

SEC Filings (Institutional Ownership Changes) for Deciphera Pharmaceuticals (NASDAQ:DCPH)

70.96% of Deciphera Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Deciphera Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/9/2024	State Board of Administration of Florida Retirement System	16,620	$0.26M	0.0%	+10.4%	0.020%
5/8/2024	ProShare Advisors LLC	15,265	$0.24M	0.0%	+9.3%	0.019%
5/8/2024	Russell Investments Group Ltd.	47,531	$0.75M	0.0%	-4.8%	0.058%
5/8/2024	Headlands Technologies LLC	2,038	$32K	0.0%	N/A	0.002%
5/8/2024	Inspire Investing LLC	25,243	$0.40M	0.0%	-7.3%	0.031%
5/8/2024	Inspire Advisors LLC	12,577	$0.20M	0.0%	-5.5%	0.015%
5/7/2024	Swiss National Bank	71,200	$1.12M	0.0%	+1.9%	0.087%
5/3/2024	Essex Investment Management Co. LLC	288,635	$4.54M	0.9%	N/A	0.351%
5/3/2024	GSA Capital Partners LLP	52,119	$0.82M	0.1%	-60.6%	0.063%
5/1/2024	Capstone Investment Advisors LLC	22,421	$0.35M	0.0%	N/A	0.027%
5/1/2024	BNP Paribas Financial Markets	36,480	$0.57M	0.0%	-53.0%	0.044%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	32,370	$0.49M	0.0%	-22.1%	0.039%
4/29/2024	Principal Financial Group Inc.	16,303	$0.26M	0.0%	-5.0%	0.020%
4/29/2024	China Universal Asset Management Co. Ltd.	15,513	$0.24M	0.0%	+67.3%	0.019%
4/18/2024	Diversified Trust Co	12,747	$0.20M	0.0%	+6.5%	0.016%
4/5/2024	Los Angeles Capital Management LLC	18,494	$0.29M	0.0%	N/A	0.023%
3/5/2024	Fisher Asset Management LLC	62,372	$1.01M	0.0%	N/A	0.077%
3/1/2024	Goldman Sachs Group Inc.	2,307,475	$37.22M	0.0%	+14.4%	2.856%
2/15/2024	Parkman Healthcare Partners LLC	561,025	$9.05M	1.3%	-6.1%	0.694%
2/15/2024	Frazier Life Sciences Management L.P.	1,021,800	$16.48M	0.9%	+176.2%	1.265%
2/14/2024	Braidwell LP	1,169,490	$18.86M	0.7%	-64.9%	1.447%
2/14/2024	Nebula Research & Development LLC	64,159	$1.04M	0.3%	+93.4%	0.079%
2/14/2024	New Leaf Venture Partners L.L.C.	576,975	$9.31M	7.5%	-52.3%	0.714%
2/13/2024	Armistice Capital LLC	5,200,000	$83.88M	1.1%	+12.7%	6.436%
2/13/2024	NEOS Investment Management LLC	18,085	$0.29M	0.0%	N/A	0.022%
2/13/2024	Campbell & CO Investment Adviser LLC	50,735	$0.82M	0.1%	N/A	0.063%
2/9/2024	Aigen Investment Management LP	22,597	$0.36M	0.1%	+58.5%	0.028%
2/9/2024	Quest Partners LLC	1,863	$30K	0.0%	N/A	0.002%
2/9/2024	Trexquant Investment LP	135,994	$2.19M	0.0%	N/A	0.170%
2/8/2024	Panagora Asset Management Inc.	235,845	$3.80M	0.0%	+157.1%	0.294%
2/7/2024	Dimensional Fund Advisors LP	1,561,654	$25.19M	0.0%	+6.3%	1.949%
2/7/2024	Jump Financial LLC	32,375	$0.52M	0.0%	N/A	0.040%
2/7/2024	Dana Investment Advisors Inc.	32,513	$0.52M	0.0%	-7.6%	0.041%
2/7/2024	BNP Paribas Financial Markets	77,653	$1.25M	0.0%	+118.1%	0.097%
2/6/2024	Charles Schwab Investment Management Inc.	515,301	$8.31M	0.0%	+2.7%	0.643%
2/6/2024	AJOVista LLC	4,695	$76K	0.1%	N/A	0.006%
2/6/2024	Swiss National Bank	69,900	$1.13M	0.0%	-19.1%	0.087%
2/6/2024	Fisher Asset Management LLC	62,372	$1.01M	0.0%	N/A	0.078%
2/5/2024	Russell Investments Group Ltd.	49,911	$0.81M	0.0%	+17.2%	0.062%
2/2/2024	Semanteon Capital Management LP	19,009	$0.31M	0.2%	N/A	0.024%
2/1/2024	New York State Common Retirement Fund	23,756	$0.38M	0.0%	+35.4%	0.030%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	12,178	$0.20M	0.0%	+20.9%	0.015%
1/30/2024	Cornercap Investment Counsel Inc.	16,673	$0.27M	0.0%	+24.6%	0.021%
1/25/2024	Allspring Global Investments Holdings LLC	21,382	$0.35M	0.0%	-70.9%	0.027%
1/25/2024	Nisa Investment Advisors LLC	22,940	$0.37M	0.0%	-9.1%	0.029%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	41,527	$0.67M	0.0%	+2.8%	0.052%
1/24/2024	DekaBank Deutsche Girozentrale	50,000	$0.82M	0.0%	N/A	0.062%
1/24/2024	China Universal Asset Management Co. Ltd.	9,272	$0.15M	0.0%	+357.7%	0.012%
1/12/2024	SG Americas Securities LLC	43,724	$0.71M	0.0%	-73.5%	0.055%
1/8/2024	Diversified Trust Co	11,969	$0.19M	0.0%	N/A	0.015%
1/5/2024	Exchange Traded Concepts LLC	10,447	$0.17M	0.0%	+34.0%	0.013%
12/18/2023	Vanguard Group Inc.	4,368,433	$55.57M	0.0%	-0.5%	5.452%
12/6/2023	Citigroup Inc.	60,580	$0.77M	0.0%	-30.0%	0.076%
11/17/2023	Jacobs Levy Equity Management Inc.	707,103	$8.99M	0.1%	-17.3%	0.883%
11/15/2023	GSA Capital Partners LLP	162,699	$2.07M	0.2%	+35.5%	0.203%
11/15/2023	Redmile Group LLC	4,475,384	$56.93M	2.7%	-8.3%	5.586%
11/15/2023	Armistice Capital LLC	4,612,000	$58.67M	0.9%	+1.1%	5.756%
11/14/2023	Braidwell LP	3,336,221	$42.44M	1.3%	-8.5%	4.164%
11/14/2023	Schonfeld Strategic Advisors LLC	232,900	$2.96M	0.0%	+2.6%	0.291%
11/14/2023	Deerfield Management Company L.P. Series C	6,897,606	$87.74M	1.9%	+2.8%	8.609%
11/14/2023	Profund Advisors LLC	24,055	$0.31M	0.0%	-42.8%	0.030%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	72,172	$0.92M	0.0%	+9.6%	0.090%
11/13/2023	Algert Global LLC	93,410	$1.19M	0.1%	N/A	0.117%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	113,000	$1.44M	0.0%	-23.1%	0.141%
11/13/2023	Dark Forest Capital Management LP	60,216	$0.77M	0.1%	+18.9%	0.075%
11/13/2023	Hsbc Holdings PLC	18,613	$0.24M	0.0%	-86.5%	0.023%
11/13/2023	Aigen Investment Management LP	14,261	$0.18M	0.0%	N/A	0.018%
11/13/2023	Rafferty Asset Management LLC	139,740	$1.78M	0.0%	-39.5%	0.174%
11/9/2023	Deutsche Bank AG	254,671	$3.24M	0.0%	+36.7%	0.318%
11/9/2023	Citigroup Inc.	60,580	$0.77M	0.0%	-30.0%	0.076%
11/9/2023	Jupiter Asset Management Ltd.	62,160	$0.79M	0.0%	+40.8%	0.078%
11/8/2023	Charles Schwab Investment Management Inc.	501,585	$6.38M	0.0%	+1.7%	0.626%
11/8/2023	Swiss National Bank	86,400	$1.10M	0.0%	-19.0%	0.108%
11/8/2023	New York Life Investment Management LLC	23,045	$0.29M	0.0%	-13.6%	0.029%
11/7/2023	Virtus ETF Advisers LLC	21,460	$0.27M	0.2%	-11.4%	0.027%
11/7/2023	Barclays PLC	114,041	$1.45M	0.0%	-19.5%	0.142%
11/7/2023	Fox Run Management L.L.C.	22,540	$0.29M	0.1%	N/A	0.028%
11/7/2023	Arizona State Retirement System	11,180	$0.14M	0.0%	-18.8%	0.014%
11/6/2023	Assenagon Asset Management S.A.	809,923	$10.30M	0.0%	-4.6%	1.011%
11/2/2023	Principal Financial Group Inc.	18,266	$0.23M	0.0%	+10.3%	0.023%
10/31/2023	Teacher Retirement System of Texas	11,903	$0.15M	0.0%	-10.6%	0.015%
10/31/2023	Panagora Asset Management Inc.	91,748	$1.17M	0.0%	N/A	0.116%
10/31/2023	China Universal Asset Management Co. Ltd.	2,026	$26K	0.0%	+96.9%	0.003%
10/27/2023	Hennion & Walsh Asset Management Inc.	33,942	$0.43M	0.0%	-16.5%	0.043%
10/27/2023	Allspring Global Investments Holdings LLC	73,553	$0.94M	0.0%	-46.9%	0.093%
10/26/2023	Inspire Investing LLC	27,532	$0.35M	0.0%	+10.4%	0.035%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	40,410	$0.51M	0.0%	-4.1%	0.051%
10/20/2023	Sunesis Advisors LLC	96,299	$1.23M	0.9%	N/A	0.122%
10/18/2023	Exchange Traded Concepts LLC	7,798	$99K	0.0%	-20.5%	0.010%
10/13/2023	SG Americas Securities LLC	165,016	$2.10M	0.0%	+7.9%	0.209%
8/15/2023	Braidwell LP	3,646,419	$51.34M	1.7%	+12.5%	4.626%
8/14/2023	Jefferies Financial Group Inc.	430,268	$6.06M	0.1%	-63.4%	0.546%
8/14/2023	Graham Capital Management L.P.	15,448	$0.22M	0.0%	N/A	0.020%
8/11/2023	Hsbc Holdings PLC	137,610	$1.94M	0.0%	N/A	0.175%
8/11/2023	Trexquant Investment LP	36,402	$0.51M	0.0%	-39.8%	0.046%
8/11/2023	E Fund Management Co. Ltd.	12,429	$0.18M	0.0%	-6.5%	0.016%
8/11/2023	ExodusPoint Capital Management LP	540,316	$7.61M	0.1%	+24.3%	0.688%
8/10/2023	Profund Advisors LLC	42,085	$0.59M	0.0%	-3.4%	0.054%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	42,127	$0.59M	0.0%	+23.7%	0.054%
8/10/2023	Jupiter Asset Management Ltd.	44,139	$0.62M	0.0%	N/A	0.056%

Data available starting January 2016

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $25.38

$25.36

$25.40

50 Day Range

MA: $17.08

$14.18

$25.38

52 Week Range

Now: $25.38

$9.90

$25.47

Volume

1,551,022 shs

Average Volume

1,260,572 shs

Market Capitalization

$2.09 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.2

Who are the company insiders with the largest holdings of Deciphera Pharmaceuticals?: Deciphera Pharmaceuticals' top insider investors include:
Brightstar Associates Llc (Major Shareholder)
Matthew L Sherman (EVP)
Thomas Patrick Kelly (CFO)
Daniel C Martin (Insider)
Jama Pitman (SVP)
Jama Pitman (Insider)
Daniel Lee Flynn (Insider)
Steven L Hoerter (CEO)
Dennis Leo Walsh (Director)
Franklin Stuart Friedman (Director)
Steven L Hoerter (CEO)
Learn More about top insider investors at Deciphera Pharmaceuticals.
Who are the major institutional investors of Deciphera Pharmaceuticals?: Deciphera Pharmaceuticals' top institutional shareholders include:
Essex Investment Management Co. LLC — 0.35%
Swiss National Bank — 0.09%
GSA Capital Partners LLP — 0.06%
Russell Investments Group Ltd. — 0.06%
BNP Paribas Financial Markets — 0.04%
Mirae Asset Global Investments Co. Ltd. — 0.04%
Learn More about top institutional investors of Deciphera Pharmaceuticals stock.
Which major investors are selling Deciphera Pharmaceuticals stock?: During the last quarter, DCPH stock was sold by these institutional investors:
GSA Capital Partners LLP
BNP Paribas Financial Markets
Mirae Asset Global Investments Co. Ltd.
Russell Investments Group Ltd.
Inspire Investing LLC
Principal Financial Group Inc.
Inspire Advisors LLC
During the last year, company insiders that have sold Deciphera Pharmaceuticals company stock include:
Brightstar Associates Llc (Major Shareholder)
Matthew L Sherman (EVP)
Thomas Patrick Kelly (CFO)
Daniel C Martin (Insider)
Jama Pitman (SVP)
Learn More investors selling Deciphera Pharmaceuticals stock.
Which major investors are buying Deciphera Pharmaceuticals stock?: During the previous quarter, DCPH stock was purchased by institutional investors including:
Essex Investment Management Co. LLC
Capstone Investment Advisors LLC
Los Angeles Capital Management LLC
China Universal Asset Management Co. Ltd.
Headlands Technologies LLC
State Board of Administration of Florida Retirement System
Swiss National Bank
ProShare Advisors LLC
Within the last year, these company insiders have bought Deciphera Pharmaceuticals stock:
Brightstar Associates Llc (Major Shareholder)
Matthew L Sherman (EVP)
Thomas Patrick Kelly (CFO)
Learn More investors buying Deciphera Pharmaceuticals stock.